541 related articles for article (PubMed ID: 31917096)
1. Seizure Characteristics, Outcome, and Risk of Epilepsy in Pediatric Anti-N-Methyl-d-Aspartate Receptor Encephalitis.
Qu XP; Vidaurre J; Peng XL; Jiang L; Zhong M; Hu Y
Pediatr Neurol; 2020 Apr; 105():35-40. PubMed ID: 31917096
[TBL] [Abstract][Full Text] [Related]
2. Clinical and electrographic features of persistent seizures and status epilepticus associated with anti-NMDA receptor encephalitis (anti-NMDARE).
Gofshteyn JS; Yeshokumar AK; Jette N; Thakur KT; Luche N; Yozawitz E; Varnado S; Klenofsky B; Tuohy MC; Ankam J; Torres S; Hesdorffer D; Nelson A; Wolf S; McGoldrick P; Yan H; Basma N; Grinspan Z
Epileptic Disord; 2020 Dec; 22(6):739-751. PubMed ID: 33258455
[TBL] [Abstract][Full Text] [Related]
3. EEG extreme delta brush: An ictal pattern in patients with anti-NMDA receptor encephalitis.
Veciana M; Becerra JL; Fossas P; Muriana D; Sansa G; Santamarina E; Gaig C; Carreño M; Molins A; Escofet C; Ley M; Vivanco R; Pedro J; Miró J; Falip M;
Epilepsy Behav; 2015 Aug; 49():280-5. PubMed ID: 26071995
[TBL] [Abstract][Full Text] [Related]
4. Seizure outcomes in patients with anti-NMDAR encephalitis: A follow-up study.
Liu X; Yan B; Wang R; Li C; Chen C; Zhou D; Hong Z
Epilepsia; 2017 Dec; 58(12):2104-2111. PubMed ID: 29098690
[TBL] [Abstract][Full Text] [Related]
5. Epileptic phenotypes, electroclinical features and clinical characteristics in 17 children with anti-NMDAR encephalitis.
Haberlandt E; Ensslen M; Gruber-Sedlmayr U; Plecko B; Brunner-Krainz M; Schimmel M; Schubert-Bast S; Neirich U; Philippi H; Kurleman G; Tardieu M; Wohlrab G; Borggraefe I; Rostásy K
Eur J Paediatr Neurol; 2017 May; 21(3):457-464. PubMed ID: 28017557
[TBL] [Abstract][Full Text] [Related]
6. Characterization and Outcomes of Epileptic Seizures in Mexican Pediatric Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Chavez-Castillo M; Ruiz-Garcia M; Herrera-Mora P
Cureus; 2020 May; 12(5):e8211. PubMed ID: 32577329
[TBL] [Abstract][Full Text] [Related]
7. Electroencephalographic findings in anti-N-methyl-d-aspartate receptor encephalitis in children: A series of 12 patients.
Yildirim M; Konuskan B; Yalnizoglu D; Topaloglu H; Erol I; Anlar B
Epilepsy Behav; 2018 Jan; 78():118-123. PubMed ID: 29179102
[TBL] [Abstract][Full Text] [Related]
8. Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABA
Shen CH; Fang GL; Yang F; Cai MT; Zheng Y; Fang W; Guo Y; Zhang YX; Ding MP
Ann Clin Transl Neurol; 2020 Aug; 7(8):1392-1399. PubMed ID: 32710704
[TBL] [Abstract][Full Text] [Related]
9. Determinants for Control of Status Epilepticus in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Yen HK; Tang SC; Tsai LK; Fan SP; Yeh SJ; Jeng JS
Acta Neurol Taiwan; 2021 Mar; 30(1)():1-10. PubMed ID: 34549395
[TBL] [Abstract][Full Text] [Related]
10. Continuous EEG Findings in Autoimmune Encephalitis.
Moise AM; Karakis I; Herlopian A; Dhakar M; Hirsch LJ; Cotsonis G; LaRoche S; Cabrera Kang CM; Westover B; Rodriguez A
J Clin Neurophysiol; 2021 Mar; 38(2):124-129. PubMed ID: 31800465
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis.
Wang Y; Yu Y; Hu Y; Li Y; Song F; Wang Y
Front Neurol; 2020; 11():280. PubMed ID: 32431657
[No Abstract] [Full Text] [Related]
12. Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: A follow-up study in East China.
Yao L; Yue W; Xunyi W; Jianhong W; Guoxing Z; Zhen H
J Clin Neurosci; 2019 Oct; 68():73-79. PubMed ID: 31331752
[TBL] [Abstract][Full Text] [Related]
13. Status Epilepticus in Patients with Anti-NMDAR Encephalitis Requiring Intensive Care: A Follow-Up Study.
Wang X; Wan J; Wei Z; Song C; Kang X; Du F; Jiang W; Yang F
Neurocrit Care; 2022 Feb; 36(1):192-201. PubMed ID: 34286465
[TBL] [Abstract][Full Text] [Related]
14. New Onset Focal Seizure Clusters in Children: Expanding the Spectrum of Anti NMDAR Encephalitis.
Roy AG; Vinayan KP; Kannoth S
Neurol India; 2020; 68(6):1374-1377. PubMed ID: 33342871
[TBL] [Abstract][Full Text] [Related]
15. Seizure characteristics, treatment, and outcome in autoimmune synaptic encephalitis: A long-term study.
Zhang W; Wang X; Shao N; Ma R; Meng H
Epilepsy Behav; 2019 May; 94():198-203. PubMed ID: 30974347
[TBL] [Abstract][Full Text] [Related]
16. Seizure Evolution and Outcome in Pediatric Autoimmune Encephalitis.
Woo H; Shim Y; Chae JH; Kim KJ; Lim BC
Pediatr Neurol; 2023 Feb; 139():35-42. PubMed ID: 36508881
[TBL] [Abstract][Full Text] [Related]
17. A mouse model of seizures in anti-N-methyl-d-aspartate receptor encephalitis.
Taraschenko O; Fox HS; Pittock SJ; Zekeridou A; Gafurova M; Eldridge E; Liu J; Dravid SM; Dingledine R
Epilepsia; 2019 Mar; 60(3):452-463. PubMed ID: 30740690
[TBL] [Abstract][Full Text] [Related]
18. Long-term seizure outcomes in patients with autoimmune encephalitis: A prospective observational registry study update.
Liu X; Guo K; Lin J; Gong X; Li A; Zhou D; Hong Z
Epilepsia; 2022 Jul; 63(7):1812-1821. PubMed ID: 35357695
[TBL] [Abstract][Full Text] [Related]
19. Analysis of electroencephalogram characteristics of anti-NMDA receptor encephalitis patients in China.
Zhang Y; Liu G; Jiang MD; Li LP; Su YY
Clin Neurophysiol; 2017 Jul; 128(7):1227-1233. PubMed ID: 28527387
[TBL] [Abstract][Full Text] [Related]
20. Refractory status epilepticus caused by anti-NMDA receptor encephalitis that markedly improved following combination therapy with rituximab and cyclophosphamide.
Kadoya M; Onoue H; Kadoya A; Ikewaki K; Kaida K
Intern Med; 2015; 54(2):209-13. PubMed ID: 25743014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
